Multi-center Prospective Survey of Inflammatory Bowel Diseases in Kerala: More Than 2000 Cases
Overview
Authors
Affiliations
Background: Inflammatory bowel disease (IBD) is considered uncommon in Asia. The aim of this study was to document the demographic characteristics and clinical aspects of ulcerative colitis (UC) and Crohn's disease (CD) in Kerala, India.
Methods: A survey of IBD in Kerala was performed. All gastroenterologists in the region were invited. From May 2013 to October 2015, data were collected in a standardized pro-forma.
Results: Forty-seven doctors in 34 centers contributed data. A total of 2142 patients were analyzed. This is the largest state-wide survey of IBD in India. Ulcerative colitis was diagnosed in 1112 (38 new), Crohn's disease in 980 (53 new), and 50 were unclassified (5 new). The district-wise distribution of IBD cases correlated with the District-wise Gross State Domestic Product (r = 0.69, p < 0.01). Three percent was below the age of 18. Patients with UC had more diarrhea (73% vs. 51%), bleeding PR (79% vs. 34%), and intermittent flares (35% vs. 13%) (all p < 0.01). Patients with CD had more abdominal pain (62% vs. 46%), weight loss (53% vs. 40%), fever (28% vs. 18%), and history of antituberculosis treatment (21% vs. 5%) (all p < 0.01). Compared to adults, children (below 18 years) were more likely to have extensive UC (58% vs. 34%, p < 0.01) and unclassified IBD (15% vs. 2%, p < 0.01).
Conclusion: Inflammatory bowel disease is common in Kerala, India. The disease characteristics of patients with IBD are almost similar to those from other parts of the country. Both UC and CD were seen in equal proportion in Kerala.
Niriella M, Martinus C, Withanage M, Darshika S, Illangasinghe M, Perera H Heliyon. 2025; 11(3):e41840.
PMID: 39931471 PMC: 11808616. DOI: 10.1016/j.heliyon.2025.e41840.
Shankar S, Majumder S, Mukherjee S, Bhaduri A, Kasturi R, Ghosh S Therap Adv Gastroenterol. 2024; 17:17562848241258360.
PMID: 39575157 PMC: 11580062. DOI: 10.1177/17562848241258360.
Biofilm's Impact on Inflammatory Bowel Diseases.
Palandurkar G, Kumar S Cureus. 2023; 15(9):e45510.
PMID: 37868553 PMC: 10585119. DOI: 10.7759/cureus.45510.
Goren I, Sharar Fischler T, Yanai H, Pal P, Adigopula B, Pendyala S J Clin Med. 2022; 11(23).
PMID: 36498474 PMC: 9737641. DOI: 10.3390/jcm11236899.
Inflammatory bowel disease: An Indian perspective.
Jain M, Venkataraman J Indian J Med Res. 2021; 153(4):421-430.
PMID: 34380788 PMC: 8354044. DOI: 10.4103/ijmr.IJMR_936_18.